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1 | INTRODUCTION
As a result of continued research and advancements in clinical prac-
tice, 5- year survival rates for pediatric heart transplant recipients 
are approaching or exceeding 80%, depending on age at transplant.1 
Given that the purpose of transplantation is not only to extend life but 
also to enhance the quality of life among this population,2 attention 
to outcomes other than survival is needed. With increasing longev-
ity of pediatric heart transplant recipients, it is important to evaluate 
the emotional, behavioral, and social functioning of these patients and 
their families throughout their post- transplant life. Furthermore, un-
derscoring its importance, recipient and parent psychosocial function-
ing is associated with health- related outcomes in pediatric solid organ 
transplant populations, including adherence to the immunosuppres-
sant regimen3,4 and number of hospitalizations.5
Results of limited studies have suggested that while the majority 
of pediatric heart transplant recipients report normative psycholog-
ical health, a subset of recipients are at increased risk for long- term 
sequelae. Approximately 30% of pediatric heart transplant recipients 
have been found to have clinically significant mental health problems 
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Abstract
Across pediatric organ transplant populations, patient and family psychosocial func-
tioning is associated with important health- related outcomes. Research has suggested 
that pediatric heart transplant recipients and their families are at increased risk for 
adverse psychosocial outcomes; however, recent investigation of psychosocial func-
tioning in this population is lacking. This study aimed to provide a contemporary char-
acterization of psychosocial functioning in pediatric heart transplant recipients and 
their families. Associations between psychosocial function, demographic variables, 
and transplant- related variables were investigated. Fifty- six parents/guardians of 
pediatric heart transplant recipients completed a comprehensive psychosocial screen-
ing measure during transplant follow- up clinic visits. Descriptive statistics, correla-
tional analyses, and independent samples t tests were performed. Forty percent of 
pediatric heart transplant recipients and their families endorsed clinically meaningful 
levels of total psychosocial risk. One- third of patients presented with clinically signifi-
cant psychological problems per parent report. Psychosocial risk was unassociated 
with demographic or transplant- related factors. Despite notable improvements in the 
survival of pediatric heart transplant recipients over the past decade, patients and 
families present with sustained psychosocial risks well beyond the immediate post- 
transplant period, necessitating mental health intervention to mitigate adverse impact 
on health- related outcomes.
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post- transplant.2,6,7 Parent and family functioning has also been found 
to be impaired in a notable portion of pediatric heart transplant recip-
ient families,8,9 which in turn is associated with more adverse psycho-
logical outcomes for patients themselves.6,10
While these early studies underscore the value of assessing psy-
chosocial functioning in pediatric heart transplant recipients and their 
families given its potential impact on health outcomes, the majority of 
published work is now quite dated and evaluated small patient sam-
ples. A recent systematic review of family functioning in pediatric solid 
organ transplant populations identified only five studies, all of which 
were greater than a decade old, that assessed parent psychological 
and/or family functioning in pediatric heart transplant samples.11 To 
our knowledge, no studies to date have screened for sibling emotional 
and behavioral problems in pediatric heart transplant populations. 
With improvements in pediatric heart transplant outcomes and ad-
vancements in post- transplant care over the past decade, it is pos-
sible that the psychosocial impact of pediatric heart transplantation 
on patients and families has also changed. Thus, a contemporary and 
expanded characterization of psychosocial functioning in pediatric 
heart transplant recipients and their families is needed to guide cur-
rent practice and research.
This study aimed to provide an updated assessment of psycho-
social functioning in pediatric heart transplant recipients, siblings, 
and parent/caregivers through the use of a validated global screen-
ing tool. A secondary aim was to evaluate use of this screening 
tool, the PAT,12 in the pediatric heart transplant population. The 
PAT, which is freely available, has been used in pediatric cancer sur-
vivor,13 infant congenital heart,14 and kidney and liver transplant 
populations.15,16 It was selected for this study due to its brief, yet 
comprehensive assessment of various domains of both modifiable 
and non- modifiable psychosocial risks, including family resources 
and support, patient and sibling emotional and behavioral func-
tioning, and parent/family stress, mental health, and illness- related 
beliefs. Thirdly, associations between psychosocial functioning, pa-
tient demographic variables, and transplant- related variables were 
also investigated. Per previous literature,11,17 it was hypothesized 
that psychosocial risk would be equally distributed across the sam-
ple, with no associations between demographic variables, primary 
disease, and time since transplant.
2  | PATIENTS AND METHODS
2.1 | Participants and methods
The current investigation was approved as a non- regulated study by 
the institutional review board at the University of Michigan Medical 
School. Legal guardians of pediatric transplant recipients of any age and 
time since transplant were asked to participate in this newly launched 
annual psychosocial screening program. Parents or legal guardians of 
56 pediatric heart transplant recipients (ages 0- 22 years) completed 
the psychosocial screening measure during their child’s regularly 
scheduled transplant follow- up clinic visit. The paper- pencil screening 
measure was given to parent/guardian by the clinic’s medical assistant 
upon being roomed. Time to complete was generally 10 minutes or 
less, and parents/guardians completed the screening measure while 
waiting to see the various providers. Upon completion, the screening 
measure was given to the pediatric transplant psychologist or psychol-
ogy trainee who briefly reviewed items prior to meeting with patient 
and families. The screening measure was used to guide in- person as-
sessment and discussion. Relevant results were also shared with clinic 
social worker prior to their meeting with patient and family. The screen-
ing measure was not regularly scored prior to mental health clinician 
seeing the patient due to high patient volume and needs during a busy 
clinic. Rather, it was scored following clinic and used to ensure patients 
and families with clinically significant psychosocial risks were sched-
uled for follow- up visits with dedicated time to meet with psychology 
and/or social work. Among our active post- transplant patient census, 
84% of patients’ parents/caregivers completed the screening measure. 
Common reasons for not completing the psychosocial screening meas-
ure included primary language other than English or Spanish (N = 1), 
parent not present at appointment with patient 18 years of age or 
older (N = 3), psychology clinician unable to meet with patient/family 
for screening (N = 6), or parent refused to complete (N = 1).
2.2 | Measures
Given its established use in other pediatric solid organ transplant 
populations,15,16 parents/caregivers completed the psychometri-
cally sound, validated PAT as a broad- based assessment of psycho-
social risk.12,18 The PAT includes seven subscales: family structure/
resources (eg, finances and number of children), family social sup-
port, child emotional/behavioral problems (eg, mood, anxiety, devel-
opment/learning, sleep, attention/behavior, and social functioning), 
sibling emotional/behavioral problems, family problems (eg, parent 
depression, anxiety, and marital discord), parent stress reactions 
(eg, intrusive memories/thoughts of child being sick, avoidance of 
places, people or things that remind the parent of their child being 
sick, hypervigilance to symptoms), and family beliefs (eg, beliefs re-
lated to child’s illness or health system). PAT scores are conceptu-
alized into a pyramid based on the PPPHM, used to describe the 
degree of patient and familial risk and determine the level of in-
tervention needed. Based upon the PPPHM pyramid (see Figure 1), 
the majority of families fall into the bottom risk category—report-
ing some degree of stress, but also a number of protective factors 
(Universal Risk). In the middle are families with moderate risks re-
quiring targeted interventions (Targeted Risk). At the top of the 
pyramid are those who indicate high levels of distress and multiple 
psychosocial risk factors (Clinical Risk). Those within the Clinical 
Risk range necessitate a high degree of psychological and sup-
portive interventions. To determine risk range, a total score rang-
ing from 0 to 7 is calculated. Total scores of <1 indicate Universal 
Risk,	1	to	<2	 indicate	Targeted	Risk,	and	≥2	 indicate	Clinical	Risk.	
Subscale	 scores	 of	 ≥0.5	 are	 clinically	 significant.12,18 Patient and 
family demographic variables were obtained via the PAT. Patient di-
agnosis, age at transplant, and time since transplant were obtained 
via medical chart review.
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2.3 | Statistical analysis
Preliminary analyses were conducted including descriptive analyses 
for the PAT, PAT total score, and subscale internal consistencies, as 
well as correlational and intergroup analyses to assess the association 
between demographic factors and PAT scores. Descriptive statistics 
are presented as frequencies and percentages for categorical vari-
ables, and means and SD for continuous variables. All analyses were 
performed using a statistical significance level of 0.05 using two- sided 
tests. Pearson correlation coefficients were calculated to detect asso-
ciations between psychosocial risk, demographic, and health- related 
variables. Independent samples t test was utilized to test differences 
in psychosocial risk based upon primary diagnosis (congenital heart 
disease, N = 21 vs cardiomyopathy/acquired heart disease, N = 34). 
Post hoc power analysis demonstrated ability to detect disease group 
differences at 0.70 level. The PAT total score was used as the com-
prehensive measure of psychosocial risk in correlational and t test 
analyses.
3  | RESULTS
3.1 | Sample demographics and descriptive statistics
Patient demographic and health- related data are reported in Table 1. 
A total of 56 parents/legal guardians, predominately mothers (79%), 
completed the PAT. Parent respondent marital status was as follows: 
married/partnered (54%), single (28%), and separated/divorced (17%). 
Of the 56 responding parents, 28 completed college/trade school and 
five completed a masters or doctoral program. Five parents indicated 
that they did not complete high school. Per parent report, the major-
ity of patients were insured via Medicaid (61%). Descriptive statistics 
and internal consistencies of the PAT total and subscale scores are 
provided in Table 2.
3.2 | Patient and family psychosocial risk
Psychosocial risk distribution among the sample is detailed in Table 3. 
The majority of pediatric heart transplant recipients and their families 
F IGURE  1 Pediatric Psychosocial 
Preventative Health Model
TABLE  1 Patient demographics
Characteristic n = 56
Mean patient age in years (SD) 11.90 (5.94)
Mean patient age at transplant in years (SD) 6.00 (5.85)










Single ventricle 21 (38.2)
Dilated cardiomyopathy 15 (27.3)
Restricted cardiomyopathy 6 (10.9)







aOne family did not respond. n = 55.
bFour families did not respond. n = 52.
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fell within the Universal Risk category (59%). These parents/guardians 
reported low levels of child, sibling, parent, and/or family problems. 
However, a significant portion of the sample fell within risk categories 
indicating need for psychosocial intervention (41%). Specifically, 30% 
of the sample endorsed stressors and problems within the Targeted 
Risk category and 11% fell within the Clinical Risk category.
With regard to subscale scores, 30% of parents/legal guardians 
endorsed clinically significant patient- specific problems. No parents/
legal guardians reported clinically significant sibling issues. Although 
very few parents/legal guardians endorsed clinically significant family 
problems (2%), such as parental depression, anxiety, substance use, or 
relational problems, 9% of respondents reported high levels of care-
giver stress reactions. Overall, the majority of parents reported having 
appropriate resources (eg, financial and transportation) and caregiving 
supports available.
Among the transplant recipients with clinically significant patient- 
specific problems, 53% were referred by transplant psychology for ad-
ditional outpatient psychology and/or neurodevelopmental evaluation 
and treatment. The majority of these patients and families followed 
through with referral. One patient was currently in local counseling, 
and continued local treatment was encouraged. The remaining pa-
tients with clinically significant patient problems (41%) were flagged 
for psychology assessment with continued monitoring of psychosocial 
functioning at their next transplant clinic visit. Among this group not 
referred for additional psychological evaluation and treatment at time 
of screening, most presented with learning/developmental risks and 
previous neurodevelopmental screening had been completed or ear-
ly- on/therapy services were already in place.
No patient demographic, temporal, or historical medical factors 
were associated with the PAT total score. Patient age at time of psy-
chosocial screening (r	=	−.03,	P = .80), sex (r	=	−.16,	P = .25), and race 
(r	=	−.20,	P = .13) were not associated with psychosocial risk. Similarly, 
age at transplant (r = .05, P = .73) and time since transplant were 
unrelated to psychosocial risk (r	=	−.12,	P = .38). Independent samples 
t test revealed no significant differences in overall psychosocial risk 
among those with congenital heart disease (M = 0.82, SD = 0.50) and 
those with a cardiomyopathy or other acquired heart disease (M = 1.0, 
SD = 0.84; t(53)	=	−0.93,	P = .36). Similarly, there were no significant 
differences in patient psychosocial risk among the congenital heart 
disease (M = 0.28, SD = 0.20) and cardiomyopathy/other acquired 
heart disease groups (M = 0.33, SD = 0.25.; t(49)	=	−0.76,	P = .45).
4  | DISCUSSION
4.1 | Patient and family psychosocial risk
While pediatric heart transplantation offers increased survival and 
improved physical functioning for many children with end- stage 
heart failure, solid organ transplantation is a chronic condition, 
with long- term risk for rejection, comorbid medical conditions (eg, 
kidney disease, diabetes, post- transplant lymphoma), and eventual 
graft loss with potential need for retransplantation. Treatment de-
mands are notable post- heart transplant, with frequent need for 
biopsies, cardiac catheterizations, and daily medications.19 Results 
of the current study demonstrated that approximately 40% of pedi-
atric heart transplant recipients and their families endorsed clini-
cally meaningful levels of overall psychosocial risk, continuing well 
beyond the immediate post- transplant period. Consistent with 
previous psychosocial research,6,7,20 parent respondents described 
clinically significant child emotional and behavioral problems in 30% 
of the recipient sample. Although sibling emotional and behavioral 
problems were assessed with the PAT, parents did not indicate any 
concerns specific to sibling functioning. At the parent level, 9% of 
study respondents endorsed clinically significant levels of caregiver 
stress reactions.
When compared to other illness groups, rates of psychosocial risk 
in heart transplant recipients and their families are similar to those 
reported by parents of children newly diagnosed with cancer21,22 and 
TABLE  2 Psychosocial assessment tool descriptive statistics and 
internal consistencies






0.15 0.17 0- 0.71 0.48
Family social 
support
0.08 0.21 0- 1.00 0.77
Child (patient) 
problems
0.31 0.23 0- 0.89 0.83
Sibling 
problems
0.28 0.20 0- 0.45 0.86
Family beliefs 0.09 0.10 0- 0.58 0.59
Family 
problems
0.15 0.14 0- 0.50 0.45
Parent stress 
reactions
0.13 0.25 0- 1.00 0.81
Total score 0.96 0.75 0- 2.98 0.89
TABLE  3 Patient and family psychosocial risk distribution





Child (patient) problems (%)
Clinical 17 (30.4)
Non- clinical 39 (69.6)
Sibling problems (%)
Clinical 0 (0.0)
Non- clinical 56 (100)
Parent stress reactions (%)
Clinical 5 (9.1)
Non- clinical 50 (90.9)
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children 2 years post- cancer treatment.13 Rates of those falling within 
the Clinical Risk range among the current sample were approximately 
5 times those of the infant CHD sample.14 This may be due to the 
increased presence of patient- specific problems (eg, depression and 
behavioral issues) in the current study’s older transplant population, 
as well as greater time living with a chronic, life- threatening disease.
4.2 | Psychosocial risk, and demographic and health- 
related factors
Patient and family psychosocial distress can negatively impact im-
portant recipient- related outcomes, such as adherence to immuno-
suppressant regimes.4,23 As a result, adverse psychosocial outcomes 
can be incredibly costly for pediatric heart transplant recipients—
potentially resulting in rejection, graft loss, or death in the most 
extreme of cases. In an effort to inform clinical practice and iden-
tify those at greatest risk for such negative outcomes, this study 
also examined associations between psychosocial risk, demographic 
variables, and transplant- related factors. Demographic variables, in-
cluding child age, sex, and race, were unrelated to overall psycho-
social distress. Findings are generally consistent with the literature, 
where null associations between parent and family functioning, child 
age, and child sex have been reported.11 Similarly, age at transplant 
and time since transplant were not associated with psychosocial 
risk, which is consistent with findings among pediatric liver trans-
plant recipients.24 There were no differences in psychosocial risk 
among recipients with congenital heart diseases when compared to 
those with a cardiomyopathy or other acquired heart disease. As a 
result of these null associations, global psychosocial screening of all 
recipients and their families is recommended. As the current study 
demonstrates, such screening is feasible in a transplant clinic setting 
and helps to identify those in need of more intensive psychosocial 
interventions until predictive factors are better understood through 
future research.
5  | CLINICAL IMPLICATIONS
Overall, despite notable improvements in both the survival and the 
medical management of pediatric heart transplant recipients over the 
past decade, rates of patient and family psychosocial problems remain 
largely the same. Although rates of psychosocial risk in pediatric heart 
transplant recipients are similar to those found in pediatric oncol-
ogy populations,13,21,22 psychosocial research and integrated clinical 
care in pediatric heart transplantation lags behind when compared 
to pediatric cancer. For example, Pediatric Blood & Cancer recently 
featured 17 articles comprising the Standards for Psychosocial Care 
for Children with Cancer and their Families.25 These clinical guide-
lines have been adopted by various national and international cancer 
organizations and medical societies, and psychosocial providers are 
commonly involved as integrated members of multidisciplinary pedi-
atric cancer care teams. While pediatric- specific standards for psy-
chosocial care in heart transplant do not exist, the 2010 International 
Society for Heart and Lung Transplantation Guidelines for the care 
of heart transplant recipients26 recommends that each heart trans-
plant center collaborate with or include a team psychologist for regu-
lar assessment and treatment of non- adherence and depression. Per 
informal e- survey of Pediatric Heart Transplant Study membership in 
2015, fewer than 40% of responding pediatric heart transplant pro-
grams had access to psychology/psychiatry consult services and only 
1 in 5 programs reported having integrated psychology/psychiatry 
providers as part of their team.
With rates of clinically significant psychosocial problems exceed-
ing 40% among this population, psychosocial providers, including 
psychologists and social workers, should be integrated members of 
the transplant team—providing psychosocial assessment, referral, 
and intervention in conjunction with medical follow- up visits. It is 
important that screening and intervention continue well beyond the 
transplant evaluation period given the persisting psychosocial dis-
tress reported by parents. Due to limited time, quick and easy- to- 
administer screening measures, such as the PAT, can be utilized to 
identify patients and families in greatest need of intervention. Those 
reporting high levels of risk can be provided in- clinic interventions, 
such as psychoeducation about a variety of issues (eg, sleep hygiene, 
behavioral management, school services, and relaxation strategies 
for anxiety), clinician- supported problem- solving specific to family 
stressors, or referral for more intensive patient and/or parent psycho-
logical evaluation and treatment. It is also important that clinical care 
and research move beyond the identification of problems through 
the development and evaluation of transplant- specific clinical inter-
ventions. While adherence- specific patient interventions have been 
reported on,27,28 there have been no family- based intervention stud-
ies aimed at improving family functioning and decreasing parental 
stress in transplant populations. Single- day family- based cognitive 
behavioral interventions that have successfully reduced anxiety and 
post- traumatic stress symptoms in childhood cancer populations and 
their families29 can be adapted and evaluated among pediatric trans-
plant populations.
6  | LIMITATIONS AND FUTURE 
RESEARCH DIRECTIONS
It is important to highlight that results must be considered in light 
of study limitations. First, as is the case with many pediatric trans-
plant studies, the single center sample size is small. While moderately 
powered, this may have limited the ability to detect associations 
between psychosocial risk, demographic, and transplant- related fac-
tors. Secondly, although the PAT is a quick and easy- to- administer 
psychosocial screening measure, it is based upon parent report only. 
Research has shown that parents and youth often have discordant 
reports of child psychological functioning.30 Similarly, underreport-
ing among the entire sample may be present. Some families reported 
no issues on the PAT measure, but endorsed a number of problem 
areas during clinical interview and review of the screening measure 
with the program psychologist. This would mean that our sample 
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underestimates that degree of psychosocial impairment, making as-
sessment even more necessary. Lastly, the PAT was administered at 
a single clinic visit over the course of 1 year. For some pediatric heart 
transplant recipients and their families, news of rejection or need for 
hospitalization presented following completion of the PAT. Thus, 
the annual screening measure did not always capture the changing 
and unpredictable stressors that may present throughout the post- 
transplant course.
In light of such limitations, future research should seek to re-
cruit larger samples of heart transplant recipients across multiple 
transplant centers. National and international pediatric transplant 
databases should consider the addition of psychosocial measures to 
enhance our understanding of this notable problem among a pop-
ulation in need of increased psychological intervention. Brief psy-
chosocial screening measures aide providers in quickly identifying 
patient and family risks and needs that necessitate interventions; 
however, there is a notable lack of valid, reliable, and quick- to- 
administer comprehensive screening measures. Although the PAT 
covers various domains of family and patient functioning, it is based 
upon parent report only. The development of an adolescent/young 
adult version of this measure could be a noteworthy undertaking 
for future research. Additionally, longitudinal assessment of psy-
chosocial functioning will hopefully aid in the identification of time 
points or events leading to increased risk and distress for patients 
and families. Other health variables, such as treatment adherence, 
number of hospitalizations, rejection episodes, and transplant- 
related complications, as well as additional psychosocial correlates, 
including disease self- efficacy, fear of complications/retransplanta-
tion, and disease knowledge, are important factors to consider in 
future research in order to identify precipitating factors of increased 
psychosocial risk post- transplant. With over 40% of pediatric heart 
transplant recipients and their families experiencing clinically sig-
nificant psychosocial stressors, action is necessary to improve both 
physical and mental health outcomes.
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